Back to 
NATIONAL BANK OF CANADA /FI/
NATIONAL BANK OF CANADA /FI/
XERS
Showing 1 of 7 quarters
Position history for NATIONAL BANK OF CANADA /FI/'s holdings in XERIS BIOPHARMA HOLDINGS INC
No. National Bank of Canada exited its XERS (Xeris Biopharma Holdings) position in Q3 2024. Its Q2 2024 13F listed 1,890 shares worth $4,101. National Bank of Canada first reported XERS in Q1 2023 and held it in 6 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History